• Childhood Kidney Diseases
• /
• 제28권1호
• /
• pp.44-50
• /
• 2024

Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that affects multiple organs. More than half of the patients with SLE have kidney involvement, and up to 10% of patients with lupus nephritis develop end-stage renal disease (ESRD). Central nervous system (CNS) involvement in SLE occurs in 21% to 95% of patients. Severe neurological manifestations such as seizures, cerebrovascular disease, meningitis, and cerebrovascular accidents can develop in childhood-onset SLE, but cerebral infections, such as brain abscess and hemorrhage, are seldom reported in lupus nephritis, even in adults. Here, we report a rare case of childhood-onset SLE with ESRD, cerebral abscess, and hemorrhage. A 9-year-old girl diagnosed with lupus nephritis was administered high-dose steroids and immunosuppressant therapy to treat acute kidney injury (AKI) and massive proteinuria. The AKI deteriorated, and after 3 months, she developed ESRD. She received hemodialysis three times a week along with daily peritoneal dialysis to control edema. She developed seizures, and imaging showed a brain abscess. This was complicated by spontaneous cerebral hemorrhage, and she became unstable. She died shortly after the hemorrhage was discovered. In conclusion, CNS complications should always be considered in clinical practice because they increase mortality, especially in those with risk factors for infection.

• 한국방사선학회논문지
• /
• 제13권4호
• /
• pp.495-502
• /
• 2019

혈관 질환을 검사하기 위한 방법으로 방사선 장비를 이용한 검사들이 주를 이루기 때문에 본 연구를 통해 뇌혈관 질환 검사에 있어 혈관 질환 검사에 사용되는 뇌혈관 조영술과 뇌혈관 전산화단층촬영검사의 입사표면선량(ESD; Entrance Surface Dose)을 비교 분석하여 뇌혈관 질환 검사 시 사용된 선량 결과에 따른 최적의 검사 방법 선택 유도 및 선량 저감화 방안에 대해 알아보고자 하였으며, 조영제 사용량을 측정 및 평가하여 조영제로 인한 부작용 발생 우려 시 권장 할 수 있는 검사선택 방법에 대해 알아보고자 연구를 진행하게 되었다. 대상으로는 2018년 6월부터 2018년 12월까지 여수지역 병원에서 뇌혈관 전산화 단층 촬영 검사를 시행한 70명 (남43, 여27)과 2018년 6월부터 2018년 11월까지 평택지역 병원에서 뇌혈관 조영술을 시행한 61 (남34, 여27)명을 대상으로 하였고, 분석 방법으로는 입사표면선량 데이터 값을 M-view와 PACS PLUS를 통해 후향적으로 획득하였으며 조영제 측정은 실제 사용된 량을 측정하는 방법으로 진행하였다. SPSS를 이용한 T-검정 분석결과 뇌혈관 조영술의 선량이 $245.74{\pm}71.91mGy$로 전산화 단층 촬영검사의 선량 $277.79{\pm}79.65mGy$보다 $32.05{\pm}7.74mGy$만큼 낮았으며 t=3.249, p=0.017로 통계적으로 유의했고(p<0.05) 조영제 총 사용량 비교 분석 결과에선 뇌혈관 조영술 시 사용된 평균 조영제 사용량이 $55.05{\pm}17.68ml$로 전산화 단층 촬영 검사에서 사용된 70 ml의 조영제 양보다 약 14.95 ml만큼 적었으며 t=-4.548, p<0.001로 통계적으로 유의했다. 결론적으로 뇌혈관 조영술의 선량이 전산화 단층 촬영검사보다 통계적으로 유의하게 낮았고, 조영제 사용량 또한 전산화 단층 촬영검사보다 유의할 만큼 적었으므로 뇌혈관 질환 검사에 있어 뇌혈관 조영술의 활용을 늘리는 방안이 피폭선량 저감화를 위한 방법임과 동시에 조영제 사용량을 감소시킬 수 있는 방안이라 생각된다.

• 대한안전경영과학회지
• /
• 제12권2호
• /
• pp.35-40
• /
• 2010

This study collected 217 cases of court ruling statements for the cases over which administrative litigations were made regarding the acknowledgment of cerebral and cardiovascular diseases arising out of duty against Korea Labor Welfare Corporation and analyzed the factors of occurrence of cerebral hemorrhage and infarction and the Court cases of cancelation and dismissal of the litigation. As a result, due to seasonal factors, cerebral hemorrhage occurred more in the winter while cerebral infarction, in spring. The incidences for each age group were the higest in people in their 40s for cerebral hemorrhage while in those in their 50s for cerebral infarction, it turned that the incidence inside the places of business was the highest. The average days from application for care and family benefits until the confirmation of the case was 31 months on average for 34 canceled cases while 23 months for 183 dismissed ones, and the average number of months working until the occurrence of accident was 80.8 months for the 34 canceled cases while 77.6 for the 183 dismissed ones. This study has a significance in that it analyzed leading cases of confirmed administrative litigations in some cases applied for diseases due to occupational cases after the occurrence of cerebral and cardiovascular diseases but not approved, through which it is expected to be used as the basic data to reduce time and economic loss generated by the litigations to judge the acknowledgment of diseases due to occupational cases.

• 동의생리병리학회지
• /
• 제34권6호
• /
• pp.279-284
• /
• 2020

The theory of "eccentric diseases are generally due to phlegm (怪病多屬痰)" means that phlegm is a major cause for intractable diseases including cerebrovascular accident, depression, insanity, and shock from strange things or evil sprint. It has been a key foundation for the diagnosis and treatment of phlegm in traditional Korean medicine. However, the origin of the theory is not clear and controversial. In this study, we critically reviewed the origin and developing process of the theory in the viewpoints of philology and pathology in Korean medicine. Wang Yin-Jun (王隱 君) did not claim that eccentric diseases are generally due to phlegm in Taidingyangshengzhu-lun (泰定養生主論). The miscitation by following medical literature caused the misunderstanding in the meaning of Taidingyangshengzhu-lun, that phlegm can cause variable symptoms and signs. In the Ming dynasty, some poor medical doctors had tended to diagnose any difficult case as phlegm syndrome and to use Kuntan-huan (滾痰丸) as a standard herbal formula for treating phlegm syndrome. However, the tendency to categorize delicate cases easily to phlegm syndrome is not desirable. Besides, the tendency to use Kuntan-huan as a basic formula for the phlegm syndrome might cause diverse and severe adverse effects. Thus, we cannot accept the theory of eccentric diseases is generally due to phlegm without a doubt. In conclusion, this theory might be a valuable aphorism in terms of considering the possibility of the secondary pathologic factors including phlegm and blood stasis which should be considered first in case of intractable diseases.

• 동의생리병리학회지
• /
• 제18권6호
• /
• pp.1881-1891
• /
• 2004

Daejowhan-gamibang(DJG) is used to prevention and treatment of cerebrovascular disease, heart disease, dementia, hyperlipdemia circulatory disturbance. Korean traditional herbal prescriptions and herb medicines in neuronal cells, which have been used for the treatment of stroke and brain diseases in Korean traditional medicine were screened to study the antioxidant effects and its mechanism. Daejowhan-gamibang water extract(DJGWE) was tested on their antioxidant activity using radical scavenging effects against ABTS. It showed significant antioxidant capacities at 50㎍ concentration. The antioxidant activity of DJGWE was determined in the different concentration (10㎍, 50 ㎍, and 100㎍). At the same time, the antiperoxidation effects was determined. Lipid peroxidation in brain homogenates induced by NADPH and ADP-Fe/sup 2+/ was significantly inhibited by DJGWE in vitro. DJGWE showed a potent antioxidant and antiperoxidative activity, further investigation, in vitro and in vivo, will be needed for the confirm of possibility as an antioxidant therapeutic agents and their optimal treatment of brain diseases in human. In searching the mechanism of antioxidant effects of DJGWE, it showed the inhibition of activity of JNK, p38, ERK and caspase 3 induced by hypoxia. So, DJGWE should be surveyed for the use of the potential therapeutic prescription for stroke and brain degenerative diseases such as pakinson's disease, dementia.

• 보건의료산업학회지
• /
• 제5권4호
• /
• pp.1-13
• /
• 2011

The purpose of this study is to analyze the medical care utilization behavior of patients to whom treatment (surgery) is recommended after they are diagnosed with abnormal findings on health screening and factors affecting the selection of the medical institute for treatment. The data was collected from 291 patients who need treatment or surgery, according to the abnormal findings on the additional examination such as cardiac CT, brain MRI, Gastroscopy and Colonoscopy since four diseases are suspected among of 2,752 people who receive health screening. The results are as follows. First, the most common disease of patients who have abnormal findings by the diagnosis through the results of first testing is colon disease based on through the additional examination. The most common disease of patients who will get treatment (surgery) based on final diagnosis by a doctor who determines the result of health screening on the basis of diagnosis from the first testing is cardiovascular disease. Second, in terms of diseases, patients with cardiovascular disease select the medical institute where they get the health screenings as a place for treatment. Patients with cerebrovascular disease select another medical institute for treatment. Finally, the affective factors of selectivity treatment facility on health screening satisfaction were human, facility, health screening and revisit factors.

• Nuclear Medicine and Molecular Imaging
• /
• 제41권2호
• /
• pp.102-111
• /
• 2007

Dementia is a major burden for many countries including South Korea, where life expectancy is continuously growing and the proportion of aged people is rapidly growing. Neurodegenerative disorders, such as, Alzheimer disease, dementia with Lewy bodies, frontotemporal dementia, Parkinson disease, progressive supranuclear palsy, corticobasal degeneration, Huntington disease, can cause dementia, and cerebrovascular disease also can cause dementia. Depression or hypothyroidism also can cause cognitive deficits, but they are reversible by management of underlying cause unlike the forementioned dementias. Therefore these are called pseudodementia. We are entering an era of dementia care that will be based upon the identification of potentially modifiable risk factors and early disease markers, and the application of new drugs postpone progression of dementias or target specific proteins that cause dementia. Efficient pharmacologic treatment of dementia needs not only to distinguish underlying causes of dementia but also to be installed as soon as possible. Therefore, differential diagnosis and early diagnosis of dementia are utmost importance. F-18 FDG PET is useful for clarifying dementing diseases and is also useful for early detection of the diseases. Purpose of this article is to review the current value of FDG PET for dementing diseases including differential diagnosis of dementia and prediction of evolving dementia.

• Journal of Korean Neurosurgical Society
• /
• 제63권1호
• /
• pp.56-68
• /
• 2020

Objective : To analyze the incidence and treatment trends of hemorrhagic stroke (HS), according to HS subtypes, using nationwide data in Korea from January 2008 to December 2016. Methods : We used data from the national health-claim database provided by the National Health Insurance Service for 2008-2016 using the International Classification of Diseases. The crude incidence and age-standardized incidence of each disease associated with HS, which included intracranial aneurysm (IA), hypertensive intracerebral hemorrhage (ICH), and arteriovenous malformation (AVM), were calculated and additional analysis was conducted according to age and sex. Changes in trends in treatment methods and number of treatments were analyzed for each cerebrovascular disease using the Korean Classification of Diseases procedure codes. Results : In 2016, the total number of newly diagnosed adult patients with HS was 24169, showing a decrease by 7.0% since 2008; the age-standardized incidence of HS was 46.2 per 100000 person-years. The age-standardized incidence of unruptured IA (UIA) in adults was 71.4 per 100000 person-years-increased by 2.6-fold since 2008-while that of ruptured IA (RIA) was 12.6 per 100000 person-years, which had decreased at a rate of 20.3% since 2008. The number of coil embolization (CE) for UIA increased by 3.4-fold over 9 years and exceeded that of clipping since 2008. With respect to RIA, CE increased by 2.0-fold over 9 years and exceeded that of clipping from 2014. As for spontaneous ICH in adults, the age-standardized incidence was 31.3 per 100000 person-years in 2016-decreased by 34.7% since 2008-and 14.6% of patients diagnosed with ICH were treated in 2016, which was not significantly different from the proportion of patients treated since 2008. The age-standardized incidence of unruptured AVM (UAVM) was 2.0 per 100000 person-year in 2016, while that of ruptured AVM (RAVM) was 2.4 per 100000 person-years in 2016, showing a decreasing rate of 17.2% from 2008. The total number of treated patients with AVM declined since 2014. Conclusion : In Korea, age-related cerebral vascular diseases, such as RIA, ICH, and RAVM, demonstrated a declining trend in age-standardized incidence; meanwhile, UIA and UAVM demonstrated an increased trend in both crude incidence and age-standardized incidence for 9 years. The increase in the elderly population, management of hypertension, and development of diagnostic and endovascular techniques appear to have influenced this trend.

• 적정기술학회지
• /
• 제6권2호
• /
• pp.163-173
• /
• 2020

ODA 사업을 성공적으로 수행하기 위해서는 수요 국가에서 취약하고 필요한 분야가 무엇인지 정확히 아는 것이 중요하다. 보건분야는 대부분의 개발 도상국에서 우선순위의 첫 번째를 차지하고 있다. 이 연구는 ODA 프로젝트 계획에 도움이 되고자 피지에서의 비전염병 질환(NCD) 상황을 소개하기 위해 수행되었다. 2016년 피지의 주요 사망 원인은 당뇨병, 허혈성심장병, 뇌혈관질환, 만성신장질환, 하기도감염, 천식 등이다. 같은 해 한국의 주요 사망 원인은 암, 허혈성심장병, 뇌혈관질환, 폐렴, 자살, 당뇨병 순이다. 비전염성 질환으로서의 만성 질환은 생활 습관 및 소비 패턴의 변화와 인구 고령화로 인해 지속적으로 증가하고 있다. 이러한 세계적인 추세는 피지와 한국에서도 명백하며 NCD의 치료 및 관리를위한 사망률 및 개인 비용 증가에 반영된다. 많은 연구에서 개별 환자에 맞춘 지속적이고 포괄적인 치료의 필요성이 제안되었으며, 이러한 치료를 제공하기 위해 NCD 환자를 관리하는 체계적인 프로그램 개발이 권장되었다. 피지 정부는 2015-2019 년 NCD 전략계획을 개발했으며 요인별로 NCD의 유병률을 낮추려고 노력해왔다. 국가 차원의 NCD 정책을 안내하는 WHO 글로벌 행동 계획은 지역 사회 수준의 NCD 예방 및 관리 모델을 필요로 한다. 이런 측면에서 ODA도 직접적인 지원만이 아니라 시스템관리 지원도 고려할 만하다.

• 치위생과학회지
• /
• 제17권4호
• /
• pp.375-381
• /
• 2017

2002~2013년도 국민건강보험공단 표본 코호트자료를 활용하여 만 40세 이상 치주질환 환자를 대상으로 CVD 누적 치료 경험률 및 개인의 소득과 지역의 CDI의 차이에 따른 치료 경험률을 파악한 본 연구의 결론은 다음과 같다. 첫째, 치주질환이 있는 대상자에서 고혈압은 34.3%, 뇌졸중은 12.6%의 누적 치료 경험률이 확인되었다. 둘째, 치주질환이 있는 대상자에서 지역적 차이(CDI)에 따른 고혈압의 치료 경험률의 차이는, CDI가 높은 집단이 낮은 집단에 비해 치료 경험률이 높은 것으로 나타났다(p<0.001). 셋째, 치주질환이 있는 대상자에서 소득분위에 따른 고혈압 치료 경험률의 차이는, 소득분위가 낮은 집단에서 치료 경험률이 높은 것으로 확인되었다(p<0.001). 넷째, 치주질환이 있는 대상자에서 지역적 차이(CDI)에 따른 뇌졸중 치료 경험률의 차이는, CDI가 높을수록 뇌졸중 치료 경험률이 높은 것으로 나타났다(p<0.001). 다섯째, 치주질환이 있는 대상자에서 소득분위에 따른 뇌졸중 치료 경험률의 차이는, 소득분위가 높아질수록 뇌졸중의 치료 경험률이 낮은 것으로 조사되었다(p<0.001). CVD와 치주질환의 관계에 지역의 CDI와 개인의 소득은 역의 관계를 보이는 것으로 나타났다. 향후 국민의 구강 및 보건의료 소비에 있어 사회경제적, 지역간 격차 해소에 대한 정책적 대안으로, 사회경제적 취약계층에 대한 보건의료서비스 제공으로 보건의료에 대한 접근성 개선과, 공공의료기관의 확충으로 보건의료서비스의 지리적 접근성 취약지를 해결하고 동시에 보건의료서비스의 이용 가능성을 높이는 등 다각적 노력을 기울여야 할 것으로 생각된다.